Prognostic significance of Bcl-xL gene expression in human colorectal cancer

Acta Histochemica

Volumn 113, Issue 8, 2011, Pages 810-814

  Jin Song, Yang ^a,b   Zhao Xia, Wang ^c   Cheng Yu, Lv ^a   Xiao Di, Liang ^b   Ming, Sun ^b   Yuan Yuan, Guo ^b   Wei, De ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bcl xL; Colorectal cancer; Human; Immunohistochemistry; Prognosis; Reverse transcription PCR

Indexed keywords

MESSENGER RNA; PROTEIN BCL XL; TUMOR MARKER;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; CLINICAL FEATURE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; VEIN PERMEABILITY;

BCL-X PROTEIN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80855156718     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2011.01.002     Document Type: Article

References (27)

1. Boise L.H., González-García M., Postema C.E., Ding L., Lindsten T., Turka L.A., et al. Bcl-x, bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608.
2. Castilla C., Congregado B., Chinchón D., Torrubia F.J., Japón M.A., Sáez C. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology 2006, 147:4960-4967.
3. Hayward R.L., Macpherson J.S., Cummings J., Monia B.P., Smyth J.F., Jodrell D.I. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Clin Cancer Res 2003, 9:2856-2865.
4. Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene 2000, 19:6627-6631.
5. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics. CA Cancer J Clin 2008, 58:71-96.
6. Karczmarek-Borowska B., Filip A., Wojcierowski J., Smoleń A., Korobowicz E., Korszen-Pilecka I., et al. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer. Lung Cancer 2006, 51:61-69.
7. Kondo S., Shinomura Y., Kanayama S., Higashimoto Y., Miyagawa J.I., Minami T., et al. Over-expression of Bcl-xL gene in human gastric adenomas and carcinomas. Int J Cancer 1996, 68:727-730.
8. Kostanová-Poliaková D., Sabová L. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment. Neoplasma 2005, 52:441-449.
9. Krajewska M., Moss S.F., Krajewski S., Song K., Holt P.R., Reed J.C. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996, 56:2422-2427.
10. Levine B., Sinha S., Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008, 4:600-606.
11. Murray N.R., Davidson L.A., Chapkin R.S., Clay Gustafson W., Schattenberg D.G., Fields A.P. Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 1999, 145:699-711.
12. O'Neill J., Manion M., Schwartz P., Hockenbery D.M. Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. Biochim Biophys Acta 2004, 1705:43-51.
13. Rhodes J.M. Usefulness of novel tumour markers. Ann Oncol 1999, 10:118-121.
14. Soltani-Arabshahi R., Leboeuf C., Rivet J., Pisonero H., Zhao W.L., Bachelez H., et al. Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL. J Invest Dermatol 2009, 129:1703-1709.
15. Wacheck V., Selzer E., Günsberg P., Lucas T., Meyer H., Thallinger C., et al. Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells. Br J Cancer 2003, 89:1352-1357.
16. Wang Z.X., Yang J.S., Pan X., Wang J.R., Li J., Yin Y.M., et al. Functional and biological analysis of Bcl-xL expression in human osteosarcoma. Bone 2010, 47:445-454.
17. Watanabe J., Kushihata F., Honda K., Mominoki K., Matsuda S., Kobayashi N. Bcl-xL overexpression in human hepatocellular carcinoma. Int J Oncol 2002, 21:515-519.
18. Watanabe J., Kushihata F., Honda K., Sugita A., Tateishi N., Mominoki K., et al. Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 2004, 135:604-612.
19. Williams J., Lucas P.C., Griffith K.A., Choi M., Fogoros S., Hu Y.Y., et al. Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. Gynecol Oncol 2005, 96:287-295.
20. Wincewicz A., Sulkowska M., Koda M., Kanczuga-Koda L., Witkowska E., Sulkowski S. Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer. Ann N Y Acad Sci 2007, 1095:53-61.
21. Wong W.W., Puthalakath H. Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life 2008, 60:390-397.
22. Woolfson K. Tumor markers in cancer of the colon and rectum. Dis Colon Rectum 1991, 34:506-511.
23. Yip K.W., Reed J.C. Bcl-2 family proteins and cancer. Oncogene 2008, 2:6398-6406.
24. Zampino M.G., Labianca R., Beretta G., Gatta G., Lorrizo K., Braud Fd F., et al. Rectal cancer. Crit Rev Oncol Hematol 2004, 51:121-143.
25. Zhang Y.L., Pang L.Q., Wu Y., Wang X.Y., Wang C.Q., Fan Y. Significance of Bcl-xL in human colon carcinoma. World J Gastroenterol 2008, 14:3069-3073.
26. Zhao W.L., Daneshpouy M.E., Mounier N., Brière J., Leboeuf C., Plassa L.F., et al. Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood 2004, 103:695-697.
27. Zhu H., Guo W., Zhang L., Davis J.J., Teraishi F., Wu S., et al. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells. Mol Cancer Ther 2005, 4:451-456.